Scientific article
Open access

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment

Published inMolecular oncology, vol. 16, no. 22, p. 3949-3974
Publication date2022-10-11
First online date2022-10-11

We previously observed increased levels of adenosine-deaminase-acting-on-dsRNA (Adar)-dependent RNA editing during mesothelioma development in mice exposed to asbestos. The aim of this study was to characterize and assess the role of ADAR-dependent RNA editing in mesothelioma. We found that tumors and mesothelioma primary cultures have higher ADAR-mediated RNA editing compared to mesothelial cells. Unsupervised clustering of editing in different genomic regions revealed heterogeneity between tumor samples as well as mesothelioma primary cultures. ADAR2 expression levels are higher in BRCA1-associated protein 1 wild-type tumors, with corresponding changes in RNA editing in transcripts and 3'UTR. ADAR2 knockdown and rescue models indicated a role in cell proliferation, altered cell cycle, increased sensitivity to antifolate treatment and type-1 interferon signaling upregulation, leading to changes in the microenvironment in vivo. Our data indicate that RNA editing contributes to mesothelioma heterogeneity and highlights an important role of ADAR2 not only in growth regulation in mesothelioma but also chemotherapy response, in addition to regulating inflammatory response downstream of sensing nucleic acid structures.

  • BRCA-associated protein 1
  • Mesothelioma
  • RNA editing
  • Antifolate therapy
  • Tumor microenvironment
  • Type-1 interferon
  • Adenosine Deaminase / genetics
  • Adenosine Deaminase / metabolism
  • Animals
  • Drug Resistance, Neoplasm / genetics
  • Mesothelioma / genetics
  • Mesothelioma, Malignant
  • Mice
  • RNA Editing / genetics
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism
  • Tumor Microenvironment / genetics
Citation (ISO format)
HARIHARAN, Ananya et al. Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment. In: Molecular oncology, 2022, vol. 16, n° 22, p. 3949–3974. doi: 10.1002/1878-0261.13322
Main files (1)
Article (Published version)
ISSN of the journal1574-7891

Technical informations

Creation10/31/2022 2:08:00 PM
First validation10/31/2022 2:08:00 PM
Update time03/16/2023 10:29:46 AM
Status update03/16/2023 10:29:45 AM
Last indexation02/01/2024 9:28:42 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack